Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. patient breathing
Show results for

Refine by

Patient Breathing Articles & Analysis

17 news found

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Marianna University School of Medicine, Department of Respiratory Medicine, Kawasaki, Japan. “Many patients with advanced disease continue to struggle to breathe, making even simple daily tasks difficult. Having a treatment that can help patients breathe easier and live a better quality of life, without surgical ...

ByPulmonx Corporation


Cone Health using radar technology to better treat heart failure

Cone Health using radar technology to better treat heart failure

When this happens fluid builds up in the lungs and patients have trouble breathing. Cone Health is the first in the country to use a new technology to measure the amount of fluid in the lungs in the inpatient hospital setting. ...

BySensible Medical Innovations Ltd.


CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

“This is very promising news for patients with advanced COPD. We know that treatment with Zephyr Valves can provide long-term improvements in lung function, breathing, and quality of life, but for patients with collateral ventilation, this minimally invasive treatment has not been available as an option,” explains Dr. ...

ByPulmonx Corporation


N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. ...

ByN8 Medical, LLC


Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System

Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System

Lungpacer is dedicated to natural breathing by developing minimally invasive technologies designed to help patients wean off mechanical ventilation and breathe on their own. ...

ByLungpacer Medical Inc.


Woolsey Pharmaceuticals Receives Positive Opinion on Orphan Drug Application from the European Medicines Agency for the Treatment of ALS with BRAVYL

Woolsey Pharmaceuticals Receives Positive Opinion on Orphan Drug Application from the European Medicines Agency for the Treatment of ALS with BRAVYL

Additionally, there is persuasive human data from a compassionate use study in Europe, where three ALS patients were dosed with an intravenous version of BRAVYL for a month. In all three patients, decline in function was attenuated during and one month after fasudil infusions, in one patient breathing capacity increased during ...

ByWoolsey Pharmaceuticals, Inc.


Woolsey Pharmaceuticals Begins ALS Study

Woolsey Pharmaceuticals Begins ALS Study

The aim of the REAL Study (Rho-kinasE for Als Study) is to assess the preliminary safety, efficacy, of BRAVYL in patients with ALS. The open label study will enroll 20 patients at up to 10 sites. ...

ByWoolsey Pharmaceuticals, Inc.


Cairn Diagnostics Delivers Virtual Administration of its Novel 13C-Spirulina Gastric Emptying Breath Test

Cairn Diagnostics Delivers Virtual Administration of its Novel 13C-Spirulina Gastric Emptying Breath Test

GEBT is an FDA-PMA approved, CE marked, Class III in-vitro diagnostic drug-medical device combination[i]product used for measuring the rate of solid phase gastric emptying and identifying delayed gastric emptying, a condition known as gastroparesis, in patients ages 18 years and older. This innovative breath test is non-invasive, orally administered, and ...

ByCairn Diagnostics


National Patient Safety Agency Alert Concerning Nebulisers

National Patient Safety Agency Alert Concerning Nebulisers

Aerogen, vibrating mesh nebuliser, is the ideal safe solution for your hospital being a powered device as required by the alert and needing no gas flow to drive it2–4 Available in 75+ countries and benefitting over 3 million COVID-19 patients in 2020 alone5, Aerogen’s closed-circuit system is instrumental in ensuring the safe and effective delivery of drugs to your ...

ByAerogen


MediPines AGM100 Voted as Finalist in Medical Design Excellence Awards, MDEA 2021

MediPines AGM100 Voted as Finalist in Medical Design Excellence Awards, MDEA 2021

“The ultimate goal in designing and engineering this respiratory solution was to improve clinical workflow efficiency and patient outcomes. We are essentially bringing the pulmonary lab right to the patient’s ...

ByMediPines


MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies

MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies

The MediPines AGM100® The MediPines Gas Exchange Monitor, AGM100®, is a respiratory monitoring system used to rapidly and non-invasively assess a patient’s respiratory status. It is the first portable monitoring system of its kind to integrate a comprehensive set of critical parameters and respiratory measurements analyzed from two-minute samples of ...

ByMediPines


NDD’s new inline filters offer additional protection against COVID-19 during lung function tests

NDD’s new inline filters offer additional protection against COVID-19 during lung function tests

COVID-19 has had a massive impact on global healthcare systems, and the safety of both patients and healthcare professionals during lung function testing is paramount.1 In addition, as the SARS-CoV-2 virus is known to affect the lungs, there is growing research into the effects of COVID-19 on lung function post-infection.2 The EasyOne product line was originally designed with a ...

ByNDD Medical Technologies


Signifier® Medical Technologies appoints David Ritscher as Chief Engineer

Signifier® Medical Technologies appoints David Ritscher as Chief Engineer

Signifier Medical Technologies (“Signifier/the Company”), an innovator in the sleep-disordered breathing market, is pleased to announce the appointment of David Ritscher as Chief Engineer with immediate effect. ...

BySignifier Medical Technologies Ltd


Perma Pure to Showcase Highly-Selective Nafion Tubing Solutions at COMPAMED 2016

Perma Pure to Showcase Highly-Selective Nafion Tubing Solutions at COMPAMED 2016

This level of performance can eliminate the use of a water trap in medical diagnostic equipment, where patient breath creates condensation that can interfere with measurement accuracy and damage equipment. Perma Pure’s ME Series solutions can also be used to introduce moisture while maintaining the purity of therapy gases, such as oxygen and nitric oxide. ...

ByPerma Pure LLC - a Halma Company


FDA Approves Breath Test To Aid In Diagnosis Of Delayed Gastric Emptying

FDA Approves Breath Test To Aid In Diagnosis Of Delayed Gastric Emptying

Food and Drug Administration today approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis. ...

ByCairn Diagnostics


Cairn Diagnostics Launches FDA-Approved Carbon-13 Spirulina Gastric Emptying Breath Test For Gastroparesis

Cairn Diagnostics Launches FDA-Approved Carbon-13 Spirulina Gastric Emptying Breath Test For Gastroparesis

Cairn Diagnostics, formerly known as Advanced Breath Diagnostics (ABDiagnostics), has launched the 13C-Spirulina Gastric Emptying Breath Test (GEBT). ...

ByCairn Diagnostics


High temperatures in cities increase hospitalisation for the elderly

High temperatures in cities increase hospitalisation for the elderly

High summer temperatures have a clear impact on rates of admission to hospital for elderly patients with breathing problems, according to new research. Although data reveals considerable variation among cities across Europe, admission rates for respiratory causes among the 75+ age group were more than twice the admission rate for all ages in all cities. ...

ByEuropean Commission, Environment DG

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT